Significant progress experimentally testing computational predictions
We have made some significant progress experimentally testing our computational predictions using nuclear magnetic resonance spectroscopy (NMR).
Read moreWe have made some significant progress experimentally testing our computational predictions using nuclear magnetic resonance spectroscopy (NMR).
Read morePlans have started to take a new approach for using FAH to fight cancer: to develop novel chaperonin inhibitors. FAH researcher Del Lucent is taking the lead. See this blog…
Read moreThe first papers on Folding@home results in regards to Huntington’s Disease were submitted.
Read moreWe are currently in the process of submitting our first paper on FAH results.
Read moreWe have submitted our first paper for peer review and we’re working on the next 2 paper right now. We’re very excited about the results!
Read moreFAH researcher Dr. Lillian Chong presented her work on p53 at a lecture at several US Universities.
Read moreWe started a pilot study on Parkinson’s Disease, and started to look for further funding to continue our work in the area.
Read moreOur first work on collagen mutations connected to Osteogenesis Imperfecta was accepted for publication.
Read moreThe first work on cancer and p53 were published. We also expanded Folding@home’s p53 work to other related systems.
Read moreThe first paper from the Pande Lab on Folding@home and Alzheimer’s Disease was submitted. In addition, Folding@home researchers Vishal Vaidyanathan and Nick Kelley presented the latest of our results on…
Read more